# MDD POC Study GSK372475 Subjects Depressive Disease

> **NCT00420641** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 492 (actual)

## Conditions studied

- Depressive Disorder

## Interventions

- **DRUG:** GSK372475
- **DRUG:** Paroxetine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00420641
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12-19
- **Primary completion:** 2008-06-01
- **Final completion:** 2008-10-15
- **Target enrollment:** 492 (ACTUAL)
- **Last updated:** 2018-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00420641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00420641, "MDD POC Study GSK372475 Subjects Depressive Disease". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00420641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*